EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy Announce Initiation of an Observational Case-control Study of Siltuximab in Patients with COVID-19...
HEMEL HEMPSTEAD, England & BERGAMO, Italy--(BUSINESS WIRE)--Mar 18, 2020-- |!| Ludington
